בית › סרטן (כל הסוגים) › פלורידה › Tampa
מחקרים קליניים עבור סרטן (כל הסוגים) ב-Tampa, FL
39 מחקרים עבור סרטן (כל הסוגים) מחפשים משתתפים באתרים ב-Tampa ובסביבתה (בטווח של כ-30 מייל). פתחו מחקר כדי לראות מי יכול להשתתף וכיצד ליצור קשר עם צוות המחקר.
טקסט רשמי של המחקר (באנגלית)
מגייסים משתתפים למחקר כאן? הציגו אותו בראש העמוד – $99 ל-30 ימים →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
מגייסשלב 2/3
- Moffitt Cancer Center /ID# 276785, Tampa
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
מגייסשלב 1
- Moffit Cancer Center, Tampa
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
מגייסשלב 1
- Moffitt Cancer Center /ID# 279068, Tampa
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
מגייסמחקר תצפיתי
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
מגייסמחקר תצפיתי
- Moffitt Cancer Center, Tampa
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
מגייסשלב 1
- Moffit Cancer center, Tampa
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
מגייסשלב 3
- Moffitt Cancer Center /ID# 279732, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
מגייסשלב 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Prospective Study to Assess a Diagnostic Aid for Cancer
מגייסמחקר תצפיתי
- Avita Clinical Research, Tampa
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
מגייסמחקר תצפיתי
- Moffitt Cancer Center, Tampa
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
מגייסשלב 2/3
- USF Health Morsani Center for Advanced Healthcare, Tampa
- H. Lee Moffitt Cancer Center and Research Institute University of South Florida, Tampa
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
מגייסשלב 2
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
מגייסשלב 1/2
- Moffitt Cancer Center, Tampa
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
מגייסמתנדבים בריאים מוזמנים
- Moffitt Cancer Center, Tampa
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
מגייסשלב 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
מגייסשלב 1
- Moffitt Cancer Center, Tampa
Project: Every Child for Younger Patients With Cancer
מגייסמחקר תצפיתי
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Abatacept in Immune Checkpoint Inhibitor Myocarditis
מגייסשלב 3
- Moffitt Cancer Center, Tampa
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
מגייסמתנדבים בריאים מוזמנים
- Moffitt Cancer Center, Tampa
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
מגייסשלב 1/2
- Moffitt Cancer Center /ID# 272628, Tampa
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
מגייסשלב 2
- Moffitt Cancer Center /ID# 274372, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
מגייסשלב 1/2
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
מגייסשלב 2
- Moffitt Cancer Center, Tampa
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
מגייסשלב 1/2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
מגייסשלב 1/2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
מגייסשלב 1/2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
מגייסשלב 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Galleri® in the Medicare Population.
מגייסמתנדבים בריאים מוזמנים
- USF Morsani Center for Advanced Healthcare, Tampa
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
מגייסשלב 1
- Moffitt Cancer Center, Tampa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
מגייסשלב 2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
מגייסשלב 2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
מגייסשלב 1
- Moffitt Cancer Center, Tampa
Beat Childhood Cancer Specimen Banking and Data Registry
מגייסמחקר תצפיתימתנדבים בריאים מוזמנים
- St. Joseph's Children's Hospital, Tampa
Caris Biorepository Research Protocol
מגייסמחקר תצפיתימתנדבים בריאים מוזמנים
- The University of South Florida, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
מגייסמחקר תצפיתי
- Massive Bio SYNERGY-AI site, Tampa
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
מגייס
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
מגייסשלב 1/2
- Moffitt Cancer Center, Tampa
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
מגייס
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Magnolia Campus, Tampa
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
מגייסשלב 1/2
- Moffitt Cancer Center, Tampa
מחקרים עבור סרטן (כל הסוגים) בערים אחרות
- Houston, TX121 מחקרים
- New York City, NY109 מחקרים
- Boston, MA85 מחקרים
- Los Angeles, CA74 מחקרים
- Nashville, TN65 מחקרים
- Philadelphia, PA59 מחקרים
- Washington, DC58 מחקרים
- Durham, NC58 מחקרים
- Chicago, IL51 מחקרים
- Atlanta, GA49 מחקרים
- Seattle, WA49 מחקרים
- Arlington, VA48 מחקרים
מחקרים אחרים ב-Tampa
- סרטן ריאות לא תא קטן51 מחקרים
- סרטן השד43 מחקרים
- סרטן המעי הגס והחלחולת34 מחקרים
- לוקמיה מיאלואידית חריפה29 מחקרים
- סרטן גרורתי29 מחקרים
- סרטן הריאה29 מחקרים
- סרטן הלבלב26 מחקרים
- סרטן השחלות21 מחקרים
- מלנומה19 מחקרים
- תסמונות דיספלסטיות של מח העצם19 מחקרים
- סרטן הערמונית18 מחקרים
- אי-ספיקת לב18 מחקרים
מקור: ClinicalTrials.gov, המידע אוחזר בתאריך 6 באוק׳ 2026. כל מחקר מגדיר את קריטריוני ההשתתפות שלו; צוות המחקר קובע מי יכול להשתתף.